Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.6350 (-9.35%) ($0.6350 - $0.6350) on Wed. Mar. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.19% (three month average) | RSI | 31 | Latest Price | $0.6350(-9.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.4% a day on average for past five trading days. | Weekly Trend | ANPC declines -7.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) GLD(42%) UUP(42%) USO(39%) VIXM(31%) SLV(29%) | Factors Impacting ANPC price | ANPC will decline at least -3.595% in a week (0% probabilities). XLB(-42%) XLF(-39%) REMX(-38%) EWJ(-34%) PAVE(-33%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.595% (StdDev 7.19%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.79 | 5 Day Moving Average | $0.73(-13.01%) | 10 Day Moving Average | $0.73(-13.01%) | 20 Day Moving Average | $0.79(-19.62%) | To recent high | -51.3% | To recent low | 0% | Market Cap | $N/A | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |